➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
AstraZeneca
Medtronic
Colorcon
Mallinckrodt

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

NEFAZODONE HYDROCHLORIDE Drug Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Nefazodone Hydrochloride, and when can generic versions of Nefazodone Hydrochloride launch?

Nefazodone Hydrochloride is a drug marketed by Ani Pharms Inc, Dr Reddys Labs Inc, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Roxane, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in nine NDAs.

The generic ingredient in NEFAZODONE HYDROCHLORIDE is nefazodone hydrochloride. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nefazodone Hydrochloride

A generic version of NEFAZODONE HYDROCHLORIDE was approved as nefazodone hydrochloride by TEVA on September 16th, 2003.

  Get Started Free

Drug patent expirations by year for NEFAZODONE HYDROCHLORIDE
Recent Clinical Trials for NEFAZODONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Maimonides Medical CenterPhase 2
Instituto Nacional de Salud Publica, MexicoPhase 3
Laboratorios Grossman, S.A.Phase 3

See all NEFAZODONE HYDROCHLORIDE clinical trials

Pharmacology for NEFAZODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for NEFAZODONE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
SERZONE TABLET;ORAL nefazodone hydrochloride 020152

US Patents and Regulatory Information for NEFAZODONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs NEFAZODONE HYDROCHLORIDE nefazodone hydrochloride TABLET;ORAL 076073-003 Sep 16, 2003 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Sun Pharm Inds Ltd NEFAZODONE HYDROCHLORIDE nefazodone hydrochloride TABLET;ORAL 076409-003 Sep 16, 2003 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Roxane NEFAZODONE HYDROCHLORIDE nefazodone hydrochloride TABLET;ORAL 076196-004 Sep 16, 2003 DISCN No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
Mallinckrodt
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.